In fiscal year 2020, the total assets of Japanese generics manufacturer Sawai Pharmaceuticals Co., Ltd. amounted to approximately 384.8 billion Japanese yen. This marked an increase from about 123 billion yen in fiscal 2011.
Total assets of Sawai Pharmaceutical Co., Ltd. from fiscal year 2011 to 2020 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Premium Statistic Major drug manufacturers Japan 2017, by number of products
- Premium Statistic Sawai Pharmaceutical's employee numbers 2012-2021
- Premium Statistic Sawai Pharmaceutical's net income FY 2012-2021
- Premium Statistic Sawai Pharmaceutical patent numbers FY 2012-2021
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2022
- Premium Statistic Forecasted generic drug sales in Mexico 2015-2025
- Premium Statistic Share of expenditure on pharmaceuticals in Denmark by type 2021
- Premium Statistic Major drug manufacturers Japan FY 2020, by wholesalers' sales share
- Basic Statistic Nichi-Iko's sales revenue FY 2012-2021
About the region
10
- Premium Statistic Nichi-Iko's sales share of generics in Japan FY 2012-2021
- Premium Statistic Nichi-Iko's total assets FY 2012-2021
- Basic Statistic Sawai Pharmaceutical's sales revenue FY 2012-2021
- Premium Statistic Sawai Pharmaceutical's R&D expenditure FY 2012-201
- Premium Statistic Nichi-Iko's gross profit FY 2012-2021
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Premium Statistic Net sales of leading generics makers Japan 2020
- Premium Statistic Towa Pharmaceutical's profit FY 2012-2017
- Premium Statistic Drug production value of cardiovascular agents Japan 2021, by category
- Premium Statistic Fuji Pharma's total assets FY 2013-2022
Selected statistics
10
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co total assets 2009-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
Other regions
10
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2022
- Basic Statistic Rx drugs by type used widely by older Americans 2017
- Premium Statistic Size comparison of small-moelcule drugs and biologics 2020
- Basic Statistic Market share of generics in European countries 2021
- Basic Statistic Value of pharmaceutical sales in Germany 2003-2021
- Basic Statistic Value of pharmaceutical sales in Ireland 2010-2021
- Premium Statistic Top pharmaceutical companies in Argentina 2014 by revenue
- Premium Statistic Latin America: main pharmacies 2017, by number of stores
- Premium Statistic Peru's pharmaceutical and hygiene import value 2014-2018
- Premium Statistic Pharmaceutical sales in Mexico 2015-2021
Related statistics
10
- Premium Statistic Prescription drug market sales share of LLPs Japan 2008-2019
- Premium Statistic Prescription drug market sales share of original drugs 2008-2019
- Premium Statistic Generics drug market size Japan 2005-2020
- Premium Statistic Prescription drug market sales share of generics 2008-2019
- Premium Statistic Major pharmaceutical companies in prescription drug sales Japan 2022, by distributor
- Premium Statistic Drug production value share of digestive organ agents Japan 2018, by category
- Premium Statistic Number of medical drug manufacturing plants Japan 2018, by employee size
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Takeda Pharmaceutical's revenue in FY 2016, by segment
Further related statistics
10
- Pfizer's ad spending 2008-2022
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Key figures on established biotech centers worldwide 2012-2016
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
Sawai Pharmaceutical. (September 30, 2021). Total assets of Sawai Pharmaceutical Co., Ltd. from fiscal year 2011 to 2020 (in billion Japanese yen) [Graph]. In Statista. Retrieved December 01, 2023, from https://www.statista.com/statistics/799694/sawai-pharmaceutical-total-assets/
Sawai Pharmaceutical. "Total assets of Sawai Pharmaceutical Co., Ltd. from fiscal year 2011 to 2020 (in billion Japanese yen)." Chart. September 30, 2021. Statista. Accessed December 01, 2023. https://www.statista.com/statistics/799694/sawai-pharmaceutical-total-assets/
Sawai Pharmaceutical. (2021). Total assets of Sawai Pharmaceutical Co., Ltd. from fiscal year 2011 to 2020 (in billion Japanese yen). Statista. Statista Inc.. Accessed: December 01, 2023. https://www.statista.com/statistics/799694/sawai-pharmaceutical-total-assets/
Sawai Pharmaceutical. "Total Assets of Sawai Pharmaceutical Co., Ltd. from Fiscal Year 2011 to 2020 (in Billion Japanese Yen)." Statista, Statista Inc., 30 Sep 2021, https://www.statista.com/statistics/799694/sawai-pharmaceutical-total-assets/
Sawai Pharmaceutical, Total assets of Sawai Pharmaceutical Co., Ltd. from fiscal year 2011 to 2020 (in billion Japanese yen) Statista, https://www.statista.com/statistics/799694/sawai-pharmaceutical-total-assets/ (last visited December 01, 2023)
Total assets of Sawai Pharmaceutical Co., Ltd. from fiscal year 2011 to 2020 (in billion Japanese yen) [Graph], Sawai Pharmaceutical, September 30, 2021. [Online]. Available: https://www.statista.com/statistics/799694/sawai-pharmaceutical-total-assets/